Continuing coverage: A study published Wednesday in the Journal of the American Medical Association found no difference in the outcome of patients who used their inhaled steroid medication daily versus only those who used it only when flare-ups occurred. "Our findings build on a considerable foundation of research in the field and come at a time when asthma cases are rising at an alarming rate, especially in lower-income communities,” said lead author Dr. William Calhoun, professor and vice chair for research in internal medicine at UTMB. The findings continue to receive widespread international coverage, appearing on CBS News and the Daily Mail U.K., among other outlets.